Subscribe to our blog

Your email:

Free Blog Directory

Healthcare PR Blog

Current Articles | RSS Feed RSS Feed

Biosimilars: High on Obama’s Agenda

 | Submit to Digg digg it | Submit to Reddit reddit | Add to delicious delicious | Share on Facebook Facebook | Share on Twitter Twitter | Share on LinkedIn LinkedIn 

Where is legislation on biosimilars heading?  How will this impact innovator biopharmaceutical and biotechnology companies?  What is your position on the issue? 

Please read my primer on the coming storm of biosimilars published in this month’s Pharmaceutical Executive.  http://tinyurl.com/l64pe4

This piece provides a summary overview of the situation and communication strategies to help innovator companies prepare and communicate around this issue.

-- John Kouten 

Comments

Currently, there are no comments. Be the first to post one!
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics

Receive email when someone replies.